⌘K

Login Start Free

Home/Filings/4/0000930413-10-004825

4//SEC Filing

HORAK IVAN D 4

Accession 0000930413-10-004825

CIK 0000727510other

View on SEC.gov Company Profile

Filed

Sep 16, 8:00 PM ET

Accepted

Sep 17, 7:12 PM ET

Size

26.1 KB

Accession

0000930413-10-004825

Insider Transaction Report

Form 4

Period: 2010-09-15

ENZON PHARMACEUTICALS INCENZN

EVP, R&D, Chief Scientific Off

Transactions

Exercise/Conversion
Common Stock
2010-09-16$7.14/sh+2,000$14,280→ 79,888 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2010-09-17−162,800→ 0 total
Exercise: $7.14From: 2009-09-02Exp: 2015-09-02→ Common Stock (162,800 underlying)
Exercise/Conversion
Common Stock
2010-09-15$6.97/sh+35,000$243,950→ 99,888 total
Sale
Common Stock
2010-09-15$10.81/sh−57,200$618,200→ 77,888 total
Sale
Common Stock
2010-09-17$10.63/sh−200,000$2,126,660→ 120,188 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2010-09-15−35,200→ 164,800 total
Exercise: $7.14From: 2009-09-02Exp: 2015-09-02→ Common Stock (35,200 underlying)
Exercise/Conversion
Common Stock
2010-09-17$7.14/sh+162,800$1,162,392→ 240,988 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2010-09-15−35,000→ 0 total
Exercise: $6.97From: 2009-11-23Exp: 2015-11-23→ Common Stock (35,000 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2010-09-17−79,200→ 66,500 total
Exercise: $7.40From: 2009-05-18Exp: 2016-05-18→ Common Stock (79,200 underlying)
Exercise/Conversion
Common Stock
2010-09-15$7.14/sh+35,200$251,328→ 135,088 total
Sale
Common Stock
2010-09-16$10.67/sh−1,700$18,132→ 78,188 total
Exercise/Conversion
Common Stock
2010-09-17$7.40/sh+79,200$586,080→ 320,188 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2010-09-16−2,000→ 162,800 total
Exercise: $7.14From: 2009-09-02Exp: 2015-09-02→ Common Stock (2,000 underlying)

Footnotes (5)

[F1]Sales were made solely to pay the exercise price for the options and to satisfy taxes owed in connection with such exercise.
[F2]Represents the weighted average price for sales of the shares. The shares were sold at prices ranging from $10.76 per share to $10.845 per share.
[F3]The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased or sold at each separate price.
[F4]Represents the weighted average price for sales of the shares. The shares were sold at prices ranging from $10.66 per share to $10.67 per share.
[F5]Represents the weighted average price for sales of the shares. The shares were sold at prices ranging from $10.51 per share to $10.71 per share.

Documents

1 file

4
c62784_ex.xmlPrimary

Issuer

ENZON PHARMACEUTICALS INC

CIK 0000727510

Entity typeother

Related Parties

1

filerCIK 0001247903

Filing Metadata

Form type: 4
Filed: Sep 16, 8:00 PM ET
Accepted: Sep 17, 7:12 PM ET
Size: 26.1 KB

View on SEC.gov